FIBROVA
Created by Nature.
Designed by Doctors.
Made for Women.
A BLEND OF VITAMINS D & K, GREEN TEA EXTRACT, AND CHASTETREE BERRY EXTRACT
Fibrova has been formulated to support the prevention and management of fibroids.
A Natural Approach to Fibroid Management
Over 50% of women will experience fibroids in their lives. Symptoms can vary and may include heavy period, bloating/feeling of fullness, pain with sex, frequent urination, and pelvic pressure and/or pain.
Multiple studies have shown that Vitamin D, Green Tea extract, and Chastetree Berry extract support the suppression of fibroid growth in women, encourage the shrinking of existing fibroid tumors, and reduce the severity of symptoms
1. ↑ http://www.ncbi.nlm.nih.gov/pubmed/23950663
2. ↑ http://report.nih.gov/nihfactsheets/Pdfs/UterineFibroids%28NICHD%2cORWH%29.pdf
3. https://www.nih.gov/news-events/news-releases/vitamin-d-may-reduce-risk-uterine-fibroids-according-nih-study
4. https://www.ncbi.nlm.nih.gov/pubmed/22302692
Shop Fibrova
30 DAYS FREE*
- *Free 30-day bottle when you subscribe for recurring 3-month supply
- - Billed $80.97 every three months
- - No Obligations. Cancel Anytime
30-Day Supply
- - One-time Payment
- - 30-day Supply
- - No Obligations
Monthly Subscription
- - 30 tablets - Billed Every Month
- - Save Money and Time Each Month
- - Cancel Anytime
What Are Fibroids?
Fibroids, also known as uterine leiomyomata, are noncancerous tumors of the uterus. Fibroids often result in pain and bleeding in premenopausal women, and are the leading cause of hysterectomy in the United States.
Fibroids — especially submucosal Fibroids — can cause infertility or pregnancy loss. Fibroids also raise the risk of certain pregnancy complications, such as placental abruption, fetal growth restriction and preterm delivery.
Fibroid tumors are composed of renegade muscle cells that grow into a fibrous "knot" or "mass" within the uterus. They most commonly occur in women between the ages 30 and 50. They are the most frequently seen tumors of the female reproductive system and more than 50% of women experience them at some point in time.
- In more than 99 percent of Fibroid cases, the tumors are benign (non-cancerous) however the symptoms can be severe. The most common symptoms caused by uterine Fibroids are:
- Heavy or prolonged menstrual periods
- Abnormal bleeding between menstrual periods
- Pelvic pain (caused by pressure on adjacent organs or death of part of the Fibroid tissue as it outgrows its supply of blood)
- Frequent urination
- Low back pain
- Pain during intercourse
- Enlarging abdomen from the large size of the Fibroids
Many women with Fibroids will eventually require surgical treatments such as Myomectomy Fibroid Surgery (removing only the Fibroids), Uterine Artery/Fibroid Embolization and Hysterectomy (removing the uterus with the Fibroids).
ABOUT OUR EXPERTS
Dr. Charles Ascher-Walsh, a nationally recognized physician, is a Professor and the Senior Vice-Chair for Gynecology at Icahn School of Medicine at the Mount Sinai Hospital System in New York City, one of the nation’s largest and most respected hospitals. He has also served as the Director of the Divisions of Urogynecology and Minimally Invasive Gynecologic Surgery at the Mt. Sinai Hospital and has been the fellowship director for each of these divisions. He has been named as one of the nation’s top doctors for 15 consecutive years by Castle Connolly and Vitals.
As the head of Mt. Sinai’s gynecologic research and a leader in the fields of fibroids, urinary incontinence and prolapse, Dr. Ascher-Walsh has conducted extensive research and contributed to more than 100 published papers, abstracts and text books relating to blood loss, pain and fertility as they relate to Fibroids and Fibroid surgery. He’s been a featured expert in numerous media including: The BBC Worldwide News, New York Magazine and the Huffington Post.
Dr. Ascher-Walsh received his medical degree from the State University of New York at Brooklyn, where he received top honors as a member of the Alpha Omega Alpha Society. He completed his residency in OB/GYN and his fellowship in Urogynecology and Minimally invasive Surgery at Columbia University, from which he also received a Masters in Biostatistics.